Valid for Submission
L12.2 is a billable diagnosis code used to specify a medical diagnosis of chronic bullous disease of childhood. The code L12.2 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code L12.2 might also be used to specify conditions or terms like bullous eruption of childhood, bullous pemphigoid, childhood bullous pemphigoid, chronic bullous dermatosis of childhood, chronic localized pemphigoid , conjunctivitis associated with autoimmune skin disorder, etc.
The code L12.2 is applicable for patients aged 0 through 17 years inclusive. It is clinically and virtually impossible to use this code on a patient outside the stated age range.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code L12.2:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Juvenile dermatitis herpetiformis
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code L12.2 are found in the index:
- - Dermatitis (eczematous) - L30.9
- - Disease, diseased - See Also: Syndrome;
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Bullous eruption of childhood
- Bullous pemphigoid
- Childhood bullous pemphigoid
- Chronic bullous dermatosis of childhood
- Chronic localized pemphigoid
- Conjunctivitis associated with autoimmune skin disorder
- Conjunctivitis associated with dermatitis herpetiformis
- Dermatitis herpetiformis
- Herpetiform eruption
- Hydroa herpetiformis
- Linear IgA dermatosis
- Localized pemphigoid
- Oral mucosal involvement by dermatitis herpetiformis
- LINEAR IGA BULLOUS DERMATOSIS-. autoimmune disease characterized by subepidermal blisters and linear deposition of autoantibodies at the dermoepidermal junction. the accumulated autoantibodies are of immunoglobulin a and occasionally immunoglobulin g classes against epidermal basement membrane proteins. the dermatosis is sometimes associated with malignancies and use of certain drugs e.g. vancomycin.
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|606||MINOR SKIN DISORDERS WITH MCC||09||1.511|
|607||MINOR SKIN DISORDERS WITHOUT MCC||09||0.8256|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert L12.2 to ICD-9 Code
Information for Patients
Pemphigus is an autoimmune disorder. If you have it, your immune system attacks healthy cells in your skin and mouth, causing blisters and sores. No one knows the cause. Pemphigus does not spread from person to person. It does not appear to be inherited. But some people's genes put them more at risk for pemphigus.
Pemphigoid is also an autoimmune skin disease. It leads to deep blisters that do not break easily. Pemphigoid is most common in older adults and may be fatal for older, sick patients.
Doctors diagnose pemphigus with a physical exam, a biopsy, and blood tests. The treatment of pemphigus and pemphigoid is the same: one or more medicines to control symptoms. These may include
- Steroids, which reduce inflammation
- Drugs that suppress the immune system response
- Antibiotics to treat associated infections
NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases
[Learn More in MedlinePlus]